The use of thalidomide in the treatment of intracranial tuberculomas in adults: Two case reports

Journal of Infection

Volumn 47, Issue 3, 2003, Pages 251-255

  Roberts, Mark T M ^a   Mendelson, M ^a,b   Meyer, P ^a   Carmichael, A ^a   Lever, A M L ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Thalidomide; Tuberculomas; Tuberculosis; Tuberculous meningitis

Indexed keywords

CIPROFLOXACIN; CYCLOSPORIN A; ETHAMBUTOL; METHYLPREDNISOLONE; PREDNISOLONE; RIFAMPICIN; RIFATER; STEROID; THALIDOMIDE; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIABETES MELLITUS; DIAGNOSTIC IMAGING; DOSE RESPONSE; DRUG CROSS REACTIVITY; DRUG PULSE THERAPY; FEMALE; HEMIANOPIA; HEMIPLEGIA; HUMAN; IMMUNOMODULATION; INTERNAL CAROTID ARTERY; LUMBAR PUNCTURE; MAXIMUM PERMISSIBLE DOSE; MIDDLE CEREBRAL ARTERY; MYCOBACTERIUM TUBERCULOSIS; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC CHIASM; PATHOGENESIS; PERIMETRY; SENSORY NEUROPATHY; TUBERCULOMA; TUBERCULOUS MENINGITIS; VISUAL FIELD; VISUAL IMPAIRMENT;

EID: 0141605811     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-4453(03)00077-X     Document Type: Article

References (16)

1. Medical Research Council, Streptomycin in tuberculosis trials committee. Streptomycin treatment of tuberculous meningitis. Lancet 1948;1:582-597.
2. Horne NW. A critical evaluation of corticosteroids in tuberculosis. Bibl Tuberc 1966;22:1-54.
3. Prasad K, Volmink J, Menon GR. Steroids for treating tuberculous meningitis. Cochrane Database Syst Rev 2000; 3. CD002244.
4. Afghani B, Lieberman JM. Paradoxical enlargement or development of intracranial tuberculomas during therapy: case report and review. Clin Infect Dis 1994;19(6): 1092-1099.
5. Miyoshi Y, Noda S, Murai H, Itoh H. Repeated deterioration of tuberculous meningitis due to a reduction in the corticosteroid dosage during chemotherapy. Rinsho Shinkeigaku 2000; 40(10):1018-1022.
6. Sampaio EP, Kaplan G, Miranda A, et al. The influence of thalidomide on the clinical and immunological manifestation of erythema nodosum leprosum. J Infect Dis 1993;168:408-414.
7. Tsenova L, Bergtold A, Freedman VH, Young RA, Kaplan G. Tumour necrosis factor alpha is a determinant of pathogenesis and disease progression in mycobacterial infection in the central nervous system. Proc Natl Acad Sci USA 1999;96(10): 5657-5662.
8. Tavares JL, Wangoo A, Dilworth P, Marshall B, Kotecha S, Shaw RJ. Thalidomide reduces tumour necrosis factor alpha production by human alveolar macrophages. Resp Med 1997; 91(1):31-39.
9. Moreira AL, Tsenova-Berkova L, Wang J, et al. Effect of cytokine modulation by thalidomide on the granulomatous response in murine tuberculosis. Tuber Lung Dis 1997;78(1): 47-55.
10. Tsenova L, Sokol K, Freedman VH, Kaplan G. A combination of thalidomide plus antibiotics protects rabbits from Mycobacterial meningitis-associated death. J Infect Dis 1998;177(6):1563-1572.
11. Schoeman JF, Springer P, Ravenscroft A, et al. Adjuctive thalidomide therapy of childhood tuberculous meningitis: possible anti-inflammatory role. J Child Neural 2000;15(8): 497-503.
12. Schoeman JF. Thalidomide therapy in childhood meningitis. J Child Neural 2000;15(12):838.
13. Gori A, Rossi MC, Marchetti G, et al. Clinical and immunological benefit of adjuvant therapy with thalidomide in the treatment of tuberculous disease. AIDS 2000;14(12): 1859-1861.
14. Haslett PA, Corral LG, Albert M, Kaplan G. Thalidomide costimulates primary human T lymphocytes preferentially inducing proliferation, cytokine production and cytokine responses in the CD8 + subset. J Exp Med 1998;187(11): 1885-1892.
15. Marriott JB, Clarke IA, Dredge K, Muller G, Stirling D, Dalgleish AG. Thalidomide and its analogues have distinct and opposing effects on TNF-alpha and TNFR2 during costimulation of both CD4(+) and CD8(+) T cells. Clin Exp Immunol 2002;130(1):75-84.
16. Tsenova L, Mangaliso B, Muller G, et al. Use of ImiD3, a thalidomide analog, as an adjunct to therapy for experimental tuberculous meningitis. Antimicrob Agents Chemother 2002;46(6):1887-1895.